Audax Private Equity today announced that it has completed the sale of WellSpring Consumer Healthcare to Avista Capital Partners.
Established in 1999 and headquartered in Sarasota, Florida, WellSpring is a leading marketer of iconic over-the-counter brands primarily in the skin care and gastrointestinal care categories. WellSpring’s product portfolio includes long-standing brands such as Bactine, Bonine, Emetrol, Glaxal Base, FDS, Micatin, Gelusil, Barriere, and K-Lyte. The Company sells to retailers and consumers through a network of distribution partners and direct salespeople.
Since being acquired by Audax in 2017, WellSpring has undergone a period of transformation, growth, and success, including:
- Expanding the company’s product offerings in high-growth categories with unmet consumer needs
- Bolstering R&D capabilities in-house and broadening network of innovation partners
- Driving significant growth across retail and e-commerce channels with industry-leading sales and marketing efforts
Read more: Business Wire
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.